Aflac Inc. stock edges lower as insider sales and new coverage shape sentiment

Aflac Inc. stock (ISIN US0010551028) has been trading just below USD 117 in mid-September 2026, with investors weighing fresh insider selling and cautious new analyst coverage alongside a solid dividend profile and steady earnings. As of September 18, 2026, Aflac shares closed at USD 116.33 on the New York Stock Exchange, only a small step below recent trading levels above USD 118.

Insider and major-holder sales in mid-September

The most eye-catching development for Aflac this week is insider and major-shareholder selling from its Japan affiliates, which adds a tangible new data point for sentiment. According to Investing.com on September 19, 2026, Masatoshi Koide, President and Representative Director of Aflac Life Insurance Japan, sold a total of 13,201 shares of Aflac common stock on September 16, 2026, for an aggregate value of about USD 1,557,893 at prices of USD 117.93 and a weighted average of USD 118.04 per share.

Koide’s sale followed the exercise of employee stock options and was executed in two separate tranches, underlining that the transactions were planned rather than a sudden move. After these sales, he still directly holds 76,422 Aflac shares, so the insider remains significantly invested in the company even after realizing roughly USD 1.56 million in proceeds from the September 16, 2026 trades, as reported by Investing.com.

In parallel, a large institutional shareholder also reduced its stake. According to a Form 4 summary cited by StockTitan, Japan Post Holdings Co., Ltd., which owns more than 10% of Aflac, indirectly sold a total of 13,800 Aflac shares on September 16, 2026 through entities associated with the J&A Alliance Trust. The first 2,986-share block was sold at a weighted average price of USD 116.89 per share, with prices ranging from USD 116.25 to USD 117.25, while the remaining 10,814 shares were sold at a weighted average price of USD 117.66, with trade prices between USD 117.26 and USD 118.09.

Taken together, the Koide and Japan Post transactions amount to 27,001 shares sold by Japan-connected insiders and major holders on September 16, 2026. For investors, the key takeaway is that these sales occurred at prices in a narrow band between roughly USD 116.25 and USD 118.09 and do not change the overall ownership structure dramatically, but they do create a short-term supply of shares just below the current market level.

Analyst coverage and valuation signals

Alongside the insider activity, new analyst coverage provides an additional lens on how the market values Aflac at current levels. According to Investing.com on September 19, 2026, Wolfe Research has initiated coverage of Aflac with an underperform rating and set a price target of USD 103.00 per share. With Aflac recently trading around USD 116 to USD 118, this target implies a downside of roughly 13 to 15 percent from the current market price, signalling that Wolfe sees the shares as stretched relative to its fundamental view.

Other analyst data points show a more neutral consensus. As MarketBeat reported on September 18, 2026, Aflac currently carries a consensus rating of Hold, with an average analyst price target of USD 116.62. At a recent trading price of around USD 116.20 to USD 116.33, the stock is essentially in line with that average target, suggesting limited expected upside based on the broader analyst community and highlighting the contrast with Wolfe Research’s more cautious view.

Valuation metrics mirror this mix of neutrality and caution. The Koide insider sale article notes that Aflac traded at a price-to-earnings ratio of 12.43 at the time of the September 16, 2026 transactions and cites InvestingPro analysis indicating the stock is currently overvalued relative to its estimated fair value, even though the price-to-earnings multiple is not excessive compared with the broader insurance sector. According to GuruFocus on September 18, 2026, Aflac shares traded at USD 118.01 on the day of Koide’s sale, giving the company a market capitalization of USD 58.32 billion and a price-to-GF-Value ratio of 0.91 based on a GF Value of USD 129.13, which GuruFocus labels as modestly undervalued.

For investors, the quantified comparison between the USD 118.01 trading price and the USD 129.13 GF Value suggests that Aflac could have roughly 9 to 10 percent upside to what GuruFocus considers fair value, while Wolfe’s USD 103.00 target points to double-digit downside. The consensus target around USD 116.62 sits almost exactly at the current price, underlining that Aflac stock now trades close to the center of a wide band of valuation opinions ranging from modest undervaluation to meaningful downside risk.

Dividend profile and recent earnings context

Despite the recent insider sales and cautious analyst commentary, Aflac maintains a steady shareholder-return profile anchored by regular dividends and buybacks. As a recent article on Yahoo Finance on September 19, 2026 reported, Aflac returned USD 1.3 billion to shareholders in its latest reported quarter, including USD 983 million through share repurchases. The company also declared a third-quarter dividend of USD 0.61 per share, payable on September 1, 2026 to shareholders of record as of August 19, 2026.

That USD 0.61 quarterly dividend translates into an annualized payout of USD 2.44 per share, which corresponds to a dividend yield of about 2.1 percent at a share price near USD 116.20, as noted by MarketBeat. For income-focused investors, this steady yield, combined with the substantial buyback volume in the quarter, remains a central part of the Aflac investment case.

On the earnings side, the same Yahoo Finance report highlights that Aflac’s net earnings jumped 37.7 percent in the quarter relative to the prior-year period, even though adjusted results were more modest. The article notes that Aflac trades at 15.20 times forward earnings as of September 18, 2026, a valuation that assumes stable profits rather than rapid growth. While the detailed revenue and EPS figures are not fully broken out in the snippet, the double-digit net earnings growth and the scale of capital returns underline that Aflac continues to generate significant cash from its insurance operations.

Historically, Aflac has focused on supplemental health and life insurance, with major operations in the United States and Japan. The recent insider transactions and major-holder sales from Japan-based affiliates therefore tie directly into the company’s long-standing presence in the Japanese market. For investors, the combination of strong net earnings growth, substantial buybacks, and a 2.1 percent dividend yield against a forward price-to-earnings multiple near 15.20 suggests a mature insurer that is balancing capital returns with moderate growth expectations.

Stock price level and trading data

Looking at market data, Aflac shares have recently traded in a tight range just below their mid-September highs. Per the main quote page for Aflac, the stock closed at USD 116.33 on the New York Stock Exchange on September 18, 2026, down USD 0.27 or 0.23% from the prior close, with after-hours trading showing the same USD 116.33 level at around 5:26 p.m. Eastern Time. Around the same period, other reports noted trades near USD 116.16 and USD 116.20, reflecting normal intraday fluctuations around the mid-USD 110s.

Based on figures cited by Investing.com Canada on September 18, 2026, Aflac shares were trading at USD 116.16 at the time of Japan Post’s sale, down slightly from a previous close of USD 116.81. Over the past year, the stock has delivered a 10% total return, indicating steady appreciation over a twelve-month horizon rather than sharp swings. With a price-to-earnings ratio stated at 12.36 in that report and 12.43 in the insider-sale coverage, investors can see that the exact multiple varies slightly depending on the specific earnings measure used, but in both cases the valuation sits in a moderate range for a large insurance group.

As of September 18, 2026, using the USD 118.01 trading price cited by GuruFocus, Aflac’s market capitalization stood at USD 58.32 billion, reinforcing its status as a large-cap insurer. While detailed 52-week high and low data are not broken out in the available snippets, the trading range around USD 116 to USD 118 in mid-September can be seen as close to the upper part of the past-year performance band, given the 10% one-year return mentioned by Investing.com Canada. For investors following chart levels, the recent insider and major-holder sales at prices between USD 116.25 and USD 118.09 effectively mark a short-term reference zone within that broader range.

With the reference price for Aflac set by its New York Stock Exchange listing in USD, secondary trading venues or depositary receipts are not central to the current story. The key point remains that as of September 18, 2026, Aflac stock is trading around USD 116 to USD 118, near consensus analyst targets and within shouting distance of the fair-value estimate used by GuruFocus, even as Wolfe Research’s new underperform rating and USD 103 price target highlight downside risks from these levels.

More news and analyses on Aflac Inc. stock